DECREASED PLASMA-PROTEIN BINDING OF VALPROATE IN PATIENTS WITH ACUTE HEAD TRAUMA

被引:30
|
作者
ANDERSON, GD
GIDAL, BE
HENDRYX, RJ
AWAN, AB
TEMKIN, NR
WILENSKY, AJ
WINN, HR
机构
[1] UNIV WASHINGTON,SCH PHARM,DEPT NEUROL SURG,SEATTLE,WA 98195
[2] UNIV WASHINGTON,SCH PHARM,DEPT BIOSTAT,SEATTLE,WA 98195
[3] UNIV WASHINGTON,SCH MED,SEATTLE,WA 98195
[4] UNIV WASHINGTON,SCH PUBL HLTH,SEATTLE,WA 98195
关键词
VALPROATE; PROTEIN BINDING; HYPOALBUMINEMIA; HEAD TRAUMA;
D O I
10.1111/j.1365-2125.1994.tb04304.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 One hundred and ten plasma samples were obtained from 50 patients treated with valproate for prophylaxis of post-traumatic head injuries. The samples were selected to include a wide range of albumin concentrations and were assayed for free and total valproate concentrations. Valproate binding parameters were determined from the Scatchard equation for one binding site using reweighted least squares analysis. 2 Plasma albumin concentrations were measured in 130 patients with head trauma. They started to decrease immediately after trauma, reaching a minimum at 5-7 days of approximately 24% of baseline value and did not return to normal until 1 month. 3 The free fraction of valproate varied six to seven-fold as albumin concentration ranged from 1.5 to 4.8 g 100 ml(-1) (218-696 mu mol 1(-1)). The mean association constant for binding (K-a) was 0.008 mu mol 1(-1) and the mean number of binding sites (N) was 2.0. There values were similar to those reported for valproate in otherwise healthy patients with epilepsy. 4 Because of saturable protein binding of valproate, hypoalbuminaemia may necessitate the monitoring of free valproate concentrations to avoid toxicity when valproate is used in patients with acute head injury.
引用
收藏
页码:559 / 562
页数:4
相关论文
共 50 条
  • [31] DISOPYRAMIDE PLASMA-PROTEIN BINDING
    MCCOY, HG
    LABROSSE, KR
    LANE, JR
    LESAR, TS
    MCBRIDE, JW
    DRUG INTELLIGENCE & CLINICAL PHARMACY, 1981, 15 (06): : 481 - 481
  • [32] PLASMA-PROTEIN BINDING OF NORETHISTERONE
    ODLIND, V
    VICTOR, A
    JOHANSSON, EDB
    CONTRACEPTION, 1982, 25 (05) : 457 - 462
  • [33] PLASMA-PROTEIN BINDING OF PHENCYCLIDINE
    GILES, HG
    CORRIGALL, WA
    KHOUW, V
    SELLERS, EM
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1982, 31 (01) : 77 - 82
  • [34] PLASMA-PROTEIN BINDING AND PHARMACOKINETICS OF DIPHENYLHYDANTOIN IN UREMIC PATIENTS
    ODARCEDE.I
    BORGA, O
    ACTA PHYSIOLOGICA SCANDINAVICA, 1973, : 24 - 24
  • [35] THE PLASMA-PROTEIN BINDING OF KETANSERIN IN HEALTH
    JOHNSTON, A
    LIMB, D
    HAMER, J
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 17 (02) : P230 - P230
  • [36] CARBAMAZEPINE PLASMA-PROTEIN BINDING IN PREGNANCY
    YERBY, MS
    FRIEL, P
    MILLER, D
    EPILEPSIA, 1984, 25 (05) : 661 - 661
  • [37] BINDING OF DRUGS BY ALBUMIN AND PLASMA-PROTEIN
    VALLNER, JJ
    JOURNAL OF PHARMACEUTICAL SCIENCES, 1977, 66 (04) : 447 - 465
  • [38] PLASMA-PROTEIN BINDING OF DIGITOXIN IN UREMIA
    SHOEMAN, DW
    AZARNOFF, DL
    FEDERATION PROCEEDINGS, 1972, 31 (02) : A517 - &
  • [39] PLASMA-PROTEIN BINDING OF DRUGS IN LIVER-TRANSPLANT PATIENTS
    HUANG, ML
    VENKATARAMANAN, R
    VANTHIEL, DH
    STARZL, TE
    BURCKART, GJ
    PTACHCINSKI, RJ
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1984, 35 (02) : 247 - 247
  • [40] THE VARIABILITY OF PLASMA-PROTEIN BINDING OF PHENYTOIN IN EPILEPTIC PATIENTS WITH HYPOALBUMINEMIA
    MAMADA, K
    KASUYA, Y
    HENMI, J
    TAKAHASHI, Y
    SOMEYA, K
    TAKAO, Y
    SASAKI, Y
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 1985, 105 (05): : 475 - 480